Dorsey ER et al (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939–953. https://doi.org/10.1016/S1474-4422(18)30295-3

Article  Google Scholar 

Willis AW et al (2022) Incidence of Parkinson disease in North America. NPJ Parkinsons Dis 8:1–7. https://doi.org/10.1038/s41531-022-00410-y

Article  CAS  Google Scholar 

Su D, Cui Y, He C, Yin P, Bai R, Zhu J et al (2025) Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of diseaseStudy,021. BMJ 388:e080952. https://doi.org/10.1136/bmj-2024-080952

Article  PubMed  PubMed Central  Google Scholar 

Santos-García D, de Deus Fonticoba T, Suárez Castro E, Aneiros Díaz A, McAfee D (2020) 5-2-1 criteria: a simple screening tool for identifying advanced PD patients who need an optimization of Parkinson’s treatment. Parkinsons Dis 2020:7537924. https://doi.org/10.1155/2020/7537924

Article  PubMed  PubMed Central  Google Scholar 

Luquin MR, Kulisevsky J, Martinez-Martin P, Mir P, Tolosa ES (2017) Consensus on the definition of advanced Parkinson’s disease: a neurologists-based delphi study (CEPA study). Parkinsons Dis 2017:4047392. https://doi.org/10.1155/2017/4047392

Article  PubMed  PubMed Central  Google Scholar 

Hinnell C, Hurt CS, Landau S et al (2012) Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson’s disease? Mov Disord 27(2):236–241. https://doi.org/10.1002/mds.23961

Article  PubMed  Google Scholar 

Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain 133(6):1755–1762. https://doi.org/10.1093/brain/awq059

Article  PubMed  Google Scholar 

Coelho M, Marti MJ, Sampaio C et al (2015) Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson’s disease: the Barcelona-Lisbon cohort. Eur J Neurol 22(2):305–312. https://doi.org/10.1111/ene.12567

Article  CAS  PubMed  Google Scholar 

Diamond A, Jankovic J (2006) Treatment of advanced Parkinson’s disease. Expert Rev Neurother 6(8):1181–1197. https://doi.org/10.1586/14737175.6.8.1181

Article  CAS  PubMed  Google Scholar 

Olanow CW, Calabresi P, Obeso JA (2020) Continuous dopaminergic stimulation as a treatment for Parkinson’s disease: current status and future opportunities. Mov Disord 35(10):1731–1744. https://doi.org/10.1002/mds.28215

Article  PubMed  Google Scholar 

van Wamelen DJ, Grigoriou S, Chaudhuri KR, Odin P (2018) Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson’s disease. J Park Dis 8:S65-72. https://doi.org/10.3233/JPD-181476

Article  CAS  Google Scholar 

Metta V, Dhamija RK, Batzu L et al (2023) Safety and tolerability of long-term apomorphine infusion in advanced Parkinson’s disease: an Indian multi-center (APO-IND) experience. Sci Rep 13:18681. https://doi.org/10.1038/s41598-023-46003-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prashanth LK, Jaychandran R, Seetharam R, Iyer RB (2020) Apomorphine: the initial Indian experience in relation to response tests and pumps. Ann Indian Acad Neurol 23(1):20–24. https://doi.org/10.4103/aian.AIAN_428_19

Article  CAS  PubMed  Google Scholar 

Hariz ML, Blomstedt P, Zrinzo L (2010) Deep brain stimulation between 1947 and 1987: The untold story. Neurosurgical Focus 29 (2): E1.

Gildenberg PL (2000) Fifty years of stereotactic and functional neurosurgery. In: Barrow DL, Kondziolka DS, Laws ER Jr, Traynelis VC (eds) Fifty years of neurosurgery. Lippincott Williams & Wilkins, New York, NY, pp 295–320. none [Google Scholar]

Google Scholar 

Mundinger F (1977) New stereotactic treatment of spasmodic torticollis with a brain stimulation system. Med Klin 72:1982 1986none [PubMed] [Google Scholar]

CAS  PubMed  Google Scholar 

Andy OJ (1983) Thalamic stimulation for control of movement disorders. Appl Neurophysiol 46(1–4):107–111 none [DOI] [PubMed] [Google Scholar]

CAS  PubMed  Google Scholar 

Siegfried J, Shulman J (1987) Deep brain stimulation. PACE: Pacing Clin Lectrophysiology 10(1):271–272 none [DOI] [PubMed] [Google Scholar

Article  CAS  Google Scholar 

Latour B, Woolgar S (1986) Laboratory life: the construction of scientific facts. Princeton University Pressnone [Google Scholar], Princeton, NJ

Google Scholar 

Latour B (1987) Science in action. Harvard University Pressnone [Google Scholar], Cambridge, MA

Google Scholar 

Latour B (1993) We have never been modern (transPorter C). Harvard University Pressnone [Google Scholar], Cambridge, MA

Google Scholar 

itek JL et al (2020) Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson’s disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. Lancet Neurol. ;19(6):491–501. doi: https://doi.org/10.1016/S1474-4422(20)30108-3. Epub 2020 May 26. Erratum in: Lancet Neurol. 2020;19(9):e8. https://doi.org/10.1016/S1474-4422(20)30261-1. PMID: 32470421

Petry-Schmelzer JN et al (2022) A randomized, double-blinded crossover trial of short versus conventional pulse width subthalamic deep brain stimulation in Parkinson’s disease. J Parkinsons Dis 12(5):1497–1505. https://doi.org/10.3233/JPD-213119

Article  PubMed  PubMed Central  Google Scholar 

Marceglia S et al (2022) Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson’s disease. BMJ Open 12:e049955. https://doi.org/10.1136/bmjopen-2021-049955

Article  PubMed  PubMed Central  Google Scholar 

Sem-Jacobsen CW (1966) Depth-electrographic observations related to parkinson’s disease. Recording and electrical stimulation around the third ventricle. J Neurosurg 24:388–402

Google Scholar 

Sem-Jacobsen CW (1968) Depth-Electrographic Stimulation of the Human Brain and Behavior. From Fourteen Years of Studies and Treatment of Parkinson’s Disease and Mental Disorders with Implanted Electrodes. Charles C. Thomas, Springfield, Illinois, pp 1–222

Google Scholar 

Hosobuchi Y, Adams JE, Rutkin B (1973) Chronic thalamic stimulation for the control of facial anesthesia dolorosa. Arch Neurol 29(3):158–61

Article  CAS  PubMed  Google Scholar 

DeLong MR, Strick PL (1974) Relation of basal ganglia, cerebellum, and motor cortex units to ramp and ballistic limb movements. Brain Res 71(2–3):327–335 PMID: 4219745 (NIH/NIMH, intramural)

Article  CAS  PubMed  Google Scholar 

DeLong MR, Georgopoulos AP, Crutcher MD, Mitchell SJ, Richardson RT, Alexander GE (1984) Functional organization of the basal ganglia: contributions of single-cell recording studies. Ciba Found Symp 107:64–82 (PMID: 6389041)

CAS  PubMed  Google Scholar 

Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J (1987) Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50(1–6):344–6

CAS  PubMed  Google Scholar 

Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, de Rougemont J (1991) Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337(8738):403–406 PMID: 1671433 (French government)

Article  CAS  PubMed  Google Scholar 

Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249(4975):1436–1438 PMID: 2402638 (NIH/NINDS, grant NS15417; private funds)

Article  CAS  PubMed  Google Scholar 

Aziz TZ, Peggs D, Sambrook MA, Crossman AR (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 6(4):288–292 PMID: 1758446 (UK)

Article  CAS  PubMed  Google Scholar 

Siegfried J, Lippitz B (1994) Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35(6):1126–1129 discussion 1129-30. PMID: 7885558(Switzerland)

Article  CAS  PubMed  Google Scholar 

FDA Premarket Approval (PMA) Database (2025) Medtronic activa parkinson’s control system. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P960009S007

FDA Humanitarian Device Exemption (HDE) Database (2025) Medtronic activa deep brain stimulation (DBS) system. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfhde/hde.cfm?id=375511

Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD (2009) CSP 468 study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301(1):63–73 PMID: 19126811 (NINDS, VA, Medtronic)

Article  CAS  PubMed  PubMed Central